(Q42453395)

31 October 2017

title

Sustained improvement in tardive dyskinesia with diazepam: indirect evidence for corticolimbic involvement (English)

1 reference

31 October 2017

Sustained improvement in tardive dyskinesia with diazepam: Indirect evidence for corticolimbic involvement (English)

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

25 September 2023

0 references

1 reference

M. M. Singh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6313141

25 September 2023

R. E. Becker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6313141

25 September 2023

R. K. Pitman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6313141

25 September 2023

H. A. Nasrallah

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6313141

25 September 2023

H. Lal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6313141

25 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6313141

25 September 2023

publication date

1 August 1983

1 reference

full work available at URL

31 October 2017

https://api.elsevier.com/content/article/PII:0361923083901880?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

https://api.elsevier.com/content/article/PII:0361923083901880?httpAccept=text/plain

25 September 2023

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

25 September 2023

published in

Brain Research Bulletin

1 reference

31 October 2017

volume

11

1 reference

31 October 2017

issue

2

1 reference

31 October 2017

page(s)

179-185

1 reference

Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra.

31 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Benzodiazepines: clinical pharmacology and therapeutic use.

25 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Acute and chronic haloperidol treatment: effects on nigrostriatal dopaminergic system activity

25 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Paradoxical response to dopamine agonists in tardive dyskinesia

25 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Dopaminergic supersensitivity: Influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia

25 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Molecular Mechanisms in the Receptor Action of Benzodiazepines

25 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Molecular Mechanisms Mediating the Action of Diazepam on GABA Receptors

25 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Chronic involuntary movements induced by phenothiazines

25 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

PERSISTENT ORAL DYSKINESIA IN TREATMENT WITH PHENOTHIAZINE DERIVATIVES

25 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol

25 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Alteration in the action of cholinergic and anti cholinergic drugs after chronic haloperidol: Indirect evidence for cholinergic hyposensitivity

25 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Persistent Phenothiazine Dyskinesia Treated with Tetrabenazine

25 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

An endogenous protein modulates the affinity of GABA and benzodiazepine receptors in rat brain

25 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Striatal control of locomotion, intentional actions and of integrating and perceptive activity

25 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Quantification of Sleepiness: A New Approach

25 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Tardive and withdrawal dyskinesia associated with haloperidol

25 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

In Search of Treatment for Tardive Dyskinesia: Review of the Literature*

25 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Studies on the action of certain pharmacological agents on tardive dyskinesia and on the rabbit syndrome

25 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Baclofen (Lioresal) in the treatment ofneuroleptic-induced tardive dyskinesia

25 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Persistent muscular restlessness after phenothiazine treatment: report of 3 cases

25 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Effect of sodium valproate on tardive dyskinesia

25 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Cerebral evolution and emotional processes: new findings on the striatal complex

25 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Evidence for glutamic acid decarboxylase-containing interneurons in the neostriatum

25 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Failure of deanol in treating tardive dyskinesia

25 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Benzodiazepine receptor: demonstration in the central nervous system

25 September 2023

36

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Letter: Clonazepam in the treatment of drug-induced dyskinesia

25 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Functional interaction between rat substantia nigra and striatum: GABA and dopamine interrelation.

25 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

More on barbiturates and tardive dyskinesia

25 September 2023

44

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Benzodiazepine binding in human brain: Characterization using [3H] flunitrazepam

25 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Benzodiazepine receptors in rat brain

25 September 2023

46

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

An anatomy of schizophrenia?

25 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Receptors for the Age of Anxiety: Pharmacology of the Benzodiazepines

25 September 2023

48

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Improvement in Tardive Dyskinesia After Muscimol Therapy

25 September 2023

49

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

Basal Ganglia: Control Function in Instrumental Behavior

25 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/0361-9230(83)90188-0

25 September 2023

Identifiers

1 reference

31 October 2017

1 reference